Brookfield Corp’s Axonics, Inc. Common Stock AXNX Stock Holding History

Brookfield Corp’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,373	Closed	-$1.01M	–	764
2022 Q3	$1.01M	Sell	14,373 -24,258	-63%	-$1.67M	﹤0.01%	531
2022 Q2	$2.19M	Buy	+38,631	New	+$2.12M	0.01%	398

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Brookfield Corp's AXNX Position: Q4 2022 in Review

Brookfield Corp sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2022, closing a stake of 14,373 shares — an estimated $1.01M sold.

Brookfield Corp first reported a position in AXNX in Q2 2022 and held it in 2 quarters. The position peaked at $2.19M in Q2 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q4 2022.

Brookfield Corp reported no remaining Axonics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Brookfield Corp sold 14,373 Axonics, Inc. Common Stock shares in Q4 2022, an estimated $1.01M.
Brookfield Corp first reported a position in Axonics, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
Brookfield Corp's Axonics, Inc. Common Stock position peaked at $2.19M in Q2 2022.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2022.

Based on Brookfield Corp's 13F filing for Q4 2022, filed 14 Feb 2023.